secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001493152-23-036364
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience enters $1.5M revenue loan agreement with Decathlon Alpha V LP
-----------------------------------------------------------------------------

- Loan amount $1,500,000, maturity June 29, 2028.
- First-priority lien on substantially all assets of INVO and its subsidiaries.
- Interest factor ranges from 35% to 100% of principal based on repayment timing.
- Proceeds: $300k to repay Cedar Advance, remainder for working capital.
- Subsidiaries guaranteed; subordination agreements with CEO, CFO related parties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223036364/0001493152-23-036364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223036364/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-036364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer